Lemonade has delivered a very large 3 year gain, yet its current market multiples and a weak value score both point to a stock that screens as expensive rather than obviously mispriced. For investors trying to make sense of Lemonade today, the question is whether that long term return profile still lines up with what the fundamentals can reasonably support.
- The share price is up about 283% over 3 years, which sets a high bar for any further payoff from here.
- Expectations around Lemonade's path to sustainable underwriting profits can support the current valuation, while any setback in loss ratios or funding needs may put pressure on the equity story.
- The broader checks treat Lemonade as overvalued, since it screens as a clear premium and scores 0 out of 6 on value tests rather than looking like a bargain.
The issue now is whether Lemonade's business can grow into this price tag or whether the past rally has already pulled forward most of the upside that the numbers can justify.
Balance that Lemonade rally by scanning hand picked alternatives that screen for stronger fundamentals through the 31 high quality undervalued stocks.
Has Lemonade Run Too Far on Sales?
P/S fits Lemonade because investors are currently focused on revenue traction far more than on earnings or book value. It is often the cleaner way to compare a high growth insurer that is still working toward consistent profits with more mature carriers.
The stock trades on a P/S of about 3.9x, versus an insurance industry average near 1.2x and a peer group around 1.9x. The tailored fair P/S ratio from the model sits lower again at roughly 1.8x, which implies the market is paying a sizable premium to what that framework suggests would be reasonable given Lemonade’s risk profile and business mix. That gap suggests the recent share price strength already reflects generous expectations for future policy volumes and revenue quality.
On this sales based yardstick, Lemonade screens as overvalued compared with both industry norms and its own modeled fair multiple.
See what the numbers say about this price — find out in our valuation breakdown.
The Lemonade Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where that Lemonade valuation puzzle leaves off. They spell out the specific growth, margin and earnings paths that would need to hold for Lemonade's current share price to look meaningfully cheap or expensive, and sit on the stock's Community page so you can see the story behind the numbers. Where a single ratio or model gives one figure, these describe the future that figure relies on so you can track whether it still stacks up.
Community narratives around Lemonade could hardly be further apart, with one side leaning into AI driven efficiency and the other fixated on how much risk is now being held on balance sheet.
Bull case: 17% undervalued
"Diversification across multiple insurance verticals (auto, renters, homeowners, pet, life) and accelerated geographical expansion in Europe reduces concentration risk and creates multiple avenues for future revenue growth and earnings stability..."
Read the full Bull Case to see why Lemonade could be undervalued
Bear case: roughly fairly valued
"Lemonade has increased its exposure to a loss ratio that has only ever been tested in benign conditions..."
Read the full Bear Case to see why Lemonade could be overvalued
Do you think there's more to the story for Lemonade? Head over to our Community to see what others are saying!
The Bottom Line
Lemonade screens as overvalued on sales based multiples, so the equity story now leans heavily on the business eventually matching those richer expectations. The valuation hinges on whether revenue quality and underwriting discipline improve fast enough to support that premium rather than forcing a reset in the P/S ratio. For holders and prospective investors, the key swing factor is whether Lemonade can convert its current growth focus into durable, profitable scale without needing materially more capital than the market already assumes.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com